Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding | Zendy

Peter Brønnum Nielsen | Zendy; Torben Bjerregaard Larsen | Zendy; Flemming Skjøth | Zendy; Anders GorstRasmussen | Zendy; Lars Hvilsted Rasmussen | Zendy; Gregory Y.H. Lip | Zendy

Open Access

Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding

Author(s) -

Peter Brønnum Nielsen,

Torben Bjerregaard Larsen,

Flemming Skjøth,

Anders GorstRasmussen,

Lars Hvilsted Rasmussen,

Gregory Y.H. Lip

Publication year - 2015

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.115.015735

Subject(s) - medicine , atrial fibrillation , stroke (engine) , hazard ratio , anticoagulant , embolism , mortality rate , complication , cardiology , surgery , confidence interval , mechanical engineering , engineering

Intracranial hemorrhage is the most feared complication of oral anticoagulant treatment. The optimal treatment option for patients with atrial fibrillation who survive an intracranial hemorrhage remains unknown. We hypothesized that restarting oral anticoagulant treatment was associated with a lower risk of stroke and mortality in comparison with not restarting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research